<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel rdf:about="https://digitallibrary.bldedu.ac.in/xmlui/handle/123456789/432">
    <title>DSpace Collection:</title>
    <link>https://digitallibrary.bldedu.ac.in/xmlui/handle/123456789/432</link>
    <description />
    <items>
      <rdf:Seq>
        <rdf:li rdf:resource="https://digitallibrary.bldedu.ac.in/xmlui/handle/123456789/5461" />
        <rdf:li rdf:resource="https://digitallibrary.bldedu.ac.in/xmlui/handle/123456789/5376" />
        <rdf:li rdf:resource="https://digitallibrary.bldedu.ac.in/xmlui/handle/123456789/5375" />
        <rdf:li rdf:resource="https://digitallibrary.bldedu.ac.in/xmlui/handle/123456789/5374" />
      </rdf:Seq>
    </items>
    <dc:date>2026-05-02T08:45:23Z</dc:date>
  </channel>
  <item rdf:about="https://digitallibrary.bldedu.ac.in/xmlui/handle/123456789/5461">
    <title>Planned Delivery or Expectant Management for Late Preterm Pre-eclampsia in Low-Income and Middle-Income Countries (CRADLE-4): A Multicentre, Open-Label, Randomized Controlled Trial</title>
    <link>https://digitallibrary.bldedu.ac.in/xmlui/handle/123456789/5461</link>
    <description>Title: Planned Delivery or Expectant Management for Late Preterm Pre-eclampsia in Low-Income and Middle-Income Countries (CRADLE-4): A Multicentre, Open-Label, Randomized Controlled Trial
Authors: Shailaja Bidri
Abstract: Background Pre-eclampsia is a leading cause of maternal and perinatal mortality. Evidence regarding interventions in&#xD;
a low-income or middle-income setting is scarce. We aimed to evaluate whether planned delivery between 34+ ⁰ and 36+ ⁶&#xD;
weeks’ gestation can reduce maternal mortality and morbidity without increasing perinatal complications in India&#xD;
and Zambia.&#xD;
Methods In this parallel-group, multicentre, open-label, randomised controlled trial, we compared planned delivery&#xD;
versus expectant management in women with pre-eclampsia from 34+ ⁰ to 36+ ⁶ weeks’ gestation. Participants were&#xD;
recruited from nine hospitals and referral facilities in India and Zambia and randomly assigned to planned delivery&#xD;
or expectant management in a 1:1 ratio by a secure web-based randomisation facility hosted by MedSciNet.&#xD;
Randomisation was stratified by centre and minimised by parity, single-fetus pregnancy or multi-fetal pregnancy, and&#xD;
gestational age. The primary maternal outcome was a composite of maternal mortality or morbidity with a superiority&#xD;
hypothesis. The primary perinatal outcome was a composite of one or more of: stillbirth, neonatal death, or neonatal&#xD;
unit admission of more than 48 h with a non-inferiority hypothesis (margin of 10% difference). Analyses were by&#xD;
intention to treat, with an additional per-protocol analysis for the perinatal outcome. The trial was prospectively&#xD;
registered with ISRCTN, 10672137. The trial is closed to recruitment and all follow-up has been completed.&#xD;
Findings Between Dec 19, 2019, and March 31, 2022, 565 women were enrolled. 284 women (282 women and&#xD;
301 babies analysed) were allocated to planned delivery and 281 women (280 women and 300 babies analysed) were&#xD;
allocated to expectant management. The incidence of the primary maternal outcome was not significantly different in&#xD;
the planned delivery group (154 [55%]) compared with the expectant management group (168 [60%]; adjusted risk&#xD;
ratio [RR] 0·91, 95% CI 0·79 to 1·05). The incidence of the primary perinatal outcome by intention to treat was noninferior&#xD;
in the planned delivery group (58 [19%]) compared with the expectant management group (67 [22%]; adjusted&#xD;
risk difference –3·39%, 90% CI –8·67 to 1·90; non-inferiority p&lt;0·0001). The results from the per-protocol analysis&#xD;
were similar. There was a significant reduction in severe maternal hypertension (adjusted RR 0·83, 95% CI&#xD;
0·70 to 0·99) and stillbirth (0·25, 0·07 to 0·87) associated with planned delivery. There were 12 serious adverse&#xD;
events in the planned delivery group and 21 in the expectant management group.&#xD;
Interpretation Clinicians can safely offer planned delivery to women with late preterm pre-eclampsia, in a low-income&#xD;
or middle-income country. Planned delivery reduces stillbirth, with no increase in neonatal unit admissions or&#xD;
neonatal morbidity and reduces the risk of severe maternal hypertension. Planned delivery from 34 weeks’ gestation&#xD;
should therefore be considered as an intervention to reduce pre-eclampsia associated mortality and morbidity in&#xD;
these settings.</description>
    <dc:date>2024-01-01T00:00:00Z</dc:date>
  </item>
  <item rdf:about="https://digitallibrary.bldedu.ac.in/xmlui/handle/123456789/5376">
    <title>Unveiling histopathological alterations in placentas of pregnant women affected by Covid-19: A comprehensive analysis</title>
    <link>https://digitallibrary.bldedu.ac.in/xmlui/handle/123456789/5376</link>
    <description>Title: Unveiling histopathological alterations in placentas of pregnant women affected by Covid-19: A comprehensive analysis
Authors: Sangamesh Mathapati, Mamatha K, Laxmi Sangolli, Aruna Biradar, Sannidhi.</description>
    <dc:date>2023-01-01T00:00:00Z</dc:date>
  </item>
  <item rdf:about="https://digitallibrary.bldedu.ac.in/xmlui/handle/123456789/5375">
    <title>Prurigo of pregnancy.</title>
    <link>https://digitallibrary.bldedu.ac.in/xmlui/handle/123456789/5375</link>
    <description>Title: Prurigo of pregnancy.
Authors: Rajasri Gurulingappa Yaliwal, Aruna Biradar, Ashwini Konin, Sona Tejaswi Reddy.</description>
    <dc:date>2023-01-01T00:00:00Z</dc:date>
  </item>
  <item rdf:about="https://digitallibrary.bldedu.ac.in/xmlui/handle/123456789/5374">
    <title>Use of intramyometrial carbetocin in caesarean myomectomy to reduce hemorrhage.</title>
    <link>https://digitallibrary.bldedu.ac.in/xmlui/handle/123456789/5374</link>
    <description>Title: Use of intramyometrial carbetocin in caesarean myomectomy to reduce hemorrhage.
Authors: Rajasri G Yaliwal, Shilpa Lakshmi, Aruna M Biradar, Laxmi S Sangolli, Gauri Bankapur.</description>
    <dc:date>2023-01-01T00:00:00Z</dc:date>
  </item>
</rdf:RDF>

